+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Eluting Stent Market - Global Forecast 2026-2032- Product Image
Drug Eluting Stent Market - Global Forecast 2026-2032- Product Image
Sale

Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337072
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Drug Eluting Stent Market is projected to reach USD 6.75 Billion in 2026. It is expected to continue growing at a CAGR of 8.46%, reaching USD 11.22 Billion by 2032.

The drug eluting stent market is central to modern interventional cardiology, supporting percutaneous coronary intervention for patients with coronary artery disease by combining mechanical vessel scaffolding with controlled local delivery of antiproliferative drugs. Compared with early bare-metal stents, contemporary drug eluting stents are designed to reduce neointimal hyperplasia and restenosis while improving long-term vessel patency. Clinical adoption is being shaped by the global burden of ischemic heart disease, aging populations, diabetes prevalence, hypertension, obesity, smoking exposure, and the expanding use of minimally invasive cardiac procedures. Current innovation priorities include thinner struts, biocompatible or biodegradable polymers, improved drug-release kinetics, enhanced deliverability in complex lesions, and stent platforms suitable for high-risk anatomical and clinical profiles. Regulatory scrutiny remains rigorous because device safety, late thrombosis risk, dual antiplatelet therapy requirements, and real-world performance remain decisive factors for hospitals, physicians, payers, and health authorities.

Transformative Shifts Redefining Drug Eluting Stent Adoption

The drug eluting stent landscape is undergoing a structural shift from device-centric innovation toward evidence-led, patient-specific coronary care. Interventional cardiology programs are increasingly prioritizing outcomes in complex percutaneous coronary intervention, including multivessel disease, left main lesions, bifurcations, calcified vessels, long lesions, diabetes-associated coronary disease, and patients at high bleeding risk. This shift is increasing demand for stent systems that combine radial strength, flexibility, low crossing profile, conformability, and predictable drug release. Health systems are also placing greater emphasis on real-world evidence, post-market surveillance, and registry-based performance monitoring to validate outcomes beyond controlled trials. Procedural standards are changing as intravascular imaging, physiology-guided decision-making, lesion preparation technologies, and optimized antiplatelet strategies become more integrated with drug eluting stent implantation. At the same time, reimbursement frameworks and value-based procurement are encouraging device selection based on measurable clinical benefit, total episode-of-care efficiency, and reduced repeat revascularization rather than product features alone.

Cumulative Impact of Artificial Intelligence on Stent Innovation

Artificial intelligence is cumulatively influencing the drug eluting stent ecosystem across discovery, design, clinical workflow, and post-procedure monitoring. In device development, AI-enabled modeling can support stent geometry optimization, polymer behavior assessment, hemodynamic simulation, and prediction of restenosis or thrombosis-related risk factors under varied vessel conditions. In clinical practice, machine learning tools are increasingly being explored to improve coronary image interpretation, quantify lesion morphology, support calcium assessment, and assist procedural planning when combined with angiography, intravascular ultrasound, optical coherence tomography, or computed tomography data. AI can also strengthen patient stratification by integrating comorbidities, medication adherence patterns, bleeding risk, renal function, and prior cardiovascular events to guide stent selection and antiplatelet therapy decisions. For healthcare systems, AI-supported registry analytics and post-market surveillance can identify safety signals, procedural variation, and long-term outcome patterns more rapidly. However, adoption depends on validated algorithms, transparent clinical evidence, interoperability with cath lab systems, cybersecurity safeguards, bias mitigation, and compliance with medical device software regulations.

Key Regional Insights Across Global Drug Eluting Stent Demand

Asia-Pacific is a high-priority region for drug eluting stents due to rising cardiovascular disease burden, expanding catheterization laboratory infrastructure, growing insurance coverage, and increasing access to percutaneous coronary intervention in China, India, Japan, South Korea, Australia, and Southeast Asian markets. North America remains defined by advanced interventional cardiology capabilities, robust clinical guideline implementation, high use of intravascular imaging in complex cases, and stringent evidence expectations from regulators and payers. Latin America is progressing through broader access to cardiac care in urban centers, although affordability, reimbursement variation, and unequal specialist distribution continue to influence procedure access. Europe benefits from mature cardiology networks, strong clinical research activity, and harmonized quality expectations under evolving medical device regulations, with adoption shaped by public procurement discipline and national health technology assessment. The Middle East is expanding tertiary cardiac care capacity through specialized heart centers, medical tourism initiatives, and investments in advanced cath lab infrastructure, particularly in high-income Gulf economies. Africa presents an emerging access landscape where coronary intervention growth is concentrated in major metropolitan hospitals, while infrastructure gaps, workforce constraints, and affordability challenges continue to affect drug eluting stent availability.

Key Group Insights Shaping Stent Access and Procurement

ASEAN markets are experiencing gradual growth in drug eluting stent utilization as healthcare systems invest in tertiary cardiac centers, training programs, and broader cardiovascular screening, although procurement policies and out-of-pocket costs remain important adoption factors. The GCC is distinguished by high cardiovascular risk linked to diabetes, obesity, and sedentary lifestyles, alongside strong investment in specialty hospitals and advanced interventional cardiology infrastructure. The European Union maintains a highly regulated and evidence-driven environment where device performance, clinical safety, traceability, and post-market evidence are critical to market access and hospital procurement. BRICS economies combine substantial disease burden with expanding domestic healthcare capacity, making affordability, local manufacturing policy, public-sector tendering, and urban-rural access disparities important considerations. G7 countries generally demonstrate mature adoption of contemporary drug eluting stent platforms, supported by established reimbursement systems, clinical registries, and advanced procedural capabilities. NATO member countries overlap significantly with developed healthcare systems in North America and Europe, where hospital readiness, regulatory alignment, and supply chain resilience are increasingly relevant to cardiovascular device procurement and continuity of care.

Key Country Insights for Drug Eluting Stent Market Dynamics

The United States leads in advanced percutaneous coronary intervention practice, supported by specialized cardiac centers, clinical guideline adoption, and extensive use of real-world evidence in evaluating drug eluting stent performance. Canada emphasizes equitable access through publicly funded healthcare systems, with adoption shaped by provincial procurement, clinical appropriateness, and outcomes-based evaluation. Mexico is expanding interventional cardiology capacity in major cities, while access differences between public and private care settings influence device utilization. Brazil has a large cardiovascular disease burden and established tertiary hospitals, with reimbursement structures and regional disparities affecting access to advanced stent technologies. The United Kingdom relies on guideline-driven coronary care, national clinical audits, and cost-effectiveness assessments to guide adoption. Germany is a major European center for interventional cardiology, supported by high procedural capability, strong hospital infrastructure, and rigorous quality standards. France combines established cardiovascular care pathways with reimbursement oversight and clinical evidence requirements. Russia has invested in cardiovascular centers and acute coronary syndrome networks, though regional access and procurement dynamics remain important. Italy and Spain have mature cardiology systems, with adoption shaped by regional health authority budgets and clinical practice variation. China is rapidly advancing coronary intervention capacity through hospital expansion, physician training, domestic device development, and large patient volumes. India shows rising demand driven by coronary artery disease prevalence, urban cardiac care expansion, and affordability-sensitive purchasing. Japan is characterized by high procedural sophistication, aging demographics, and strong emphasis on safety and device quality. Australia maintains evidence-led adoption within a regulated healthcare environment and advanced specialist networks. South Korea combines high technology readiness, sophisticated hospitals, and strong clinical adoption of contemporary interventional cardiology techniques.

Actionable Recommendations for Drug Eluting Stent Leaders

Industry leaders should prioritize clinically differentiated drug eluting stent platforms that address complex lesions, high bleeding risk patients, diabetic populations, and aging patients with multiple comorbidities. Product development should focus on thinner struts, durable deliverability, optimized polymer biocompatibility, controlled drug elution, and compatibility with imaging-guided and physiology-guided PCI workflows. Evidence strategies should extend beyond pivotal trials to include real-world registries, longer-term follow-up, subgroup analyses, and transparent safety reporting on restenosis, stent thrombosis, target lesion failure, and repeat revascularization. Commercial teams should align with hospital value committees by demonstrating procedural efficiency, lifecycle value, supply reliability, and training support. Regional strategies must reflect reimbursement maturity, procurement systems, local regulatory requirements, and affordability constraints, particularly in emerging economies. Leaders should also invest in physician education, AI-enabled procedural planning partnerships, digital post-market surveillance, and supply chain resilience to maintain trust across cath lab networks and healthcare systems.

Research Methodology Grounded in Verified Evidence

This executive summary is developed using a structured secondary research methodology focused on verified clinical, regulatory, and healthcare system evidence. The approach includes analysis of peer-reviewed cardiology literature, interventional cardiology guidelines, public health data on coronary artery disease and cardiovascular risk factors, medical device regulatory documentation, hospital technology assessment practices, clinical trial findings, registry publications, and publicly available healthcare infrastructure indicators. Regional, group, and country-level insights are synthesized through cross-validation of disease burden, procedural adoption patterns, reimbursement context, cath lab capacity, regulatory expectations, and access barriers. The methodology excludes market sizing, market share, and forecasting and instead emphasizes evidence-backed qualitative analysis of adoption drivers, technology trends, policy influences, and clinical practice evolution. All findings are interpreted through the lens of drug eluting stent performance, patient outcomes, safety monitoring, and healthcare delivery readiness.

Conclusion: Evidence-Led Innovation Defines the Future of Stents

Drug eluting stents remain a foundational technology in the treatment of coronary artery disease, with continued relevance driven by improved clinical outcomes, minimally invasive intervention trends, and growing cardiovascular care needs worldwide. The sector is evolving through advanced materials, refined drug-release systems, imaging-guided implantation, AI-supported decision-making, and stronger post-market evidence expectations. Regional and country dynamics show that adoption is not uniform: mature healthcare systems emphasize evidence, safety, and value, while emerging markets focus on access expansion, affordability, infrastructure development, and physician training. Future competitive strength will depend on the ability to combine clinical differentiation with regulatory compliance, real-world performance transparency, procedural workflow integration, and reliable global supply. Stakeholders that align innovation with patient-specific care, long-term safety, and healthcare system value will be best positioned in the evolving drug eluting stent landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Drug Eluting Stent Market, by Type
7.1. Introduction
7.2. Polymer Coated
7.2.1. Biodegradable Polymer Coated
7.2.2. Durable Polymer Coated
7.3. Polymer Free
8. Drug Eluting Stent Market, by Drug
8.1. Introduction
8.2. Biolimus Eluting
8.3. Everolimus Eluting
8.4. Paclitaxel Eluting
8.5. Sirolimus Eluting
9. Drug Eluting Stent Market, by Material Type
9.1. Introduction
9.2. Metallic Stents
9.2.1. Stainless Steel Stents
9.2.2. Cobalt Chromium Stents
9.3. Bioresorbable Stents
9.3.1. Polymer Based Bioresorbable Stents
9.3.2. Magnesium Based Stents
10. Drug Eluting Stent Market, by Application
10.1. Introduction
10.2. Coronary Artery Disease
10.3. Peripheral Vascular Disease
11. Drug Eluting Stent Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
12. Drug Eluting Stent Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Drug Eluting Stent Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Drug Eluting Stent Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Drug Eluting Stent Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Acrostak AG
17.3. Amaranth Medical Inc.
17.4. B. Braun SE
17.5. Balton Sp. z o.o.
17.6. Biosensors International Group Ltd.
17.7. BIOTRONIK SE & Co. KG
17.8. Boston Scientific Corporation
17.9. Cardionovum GmbH
17.10. Concept Medical Inc.
17.11. Elixir Medical Corporation
17.12. Endocor GmbH
17.13. iVascular S.L.U.
17.14. JW Medical Systems
17.15. Lepu Medical Technology Beijing Co. Ltd.
17.16. Medinol Ltd.
17.17. Medtronic plc
17.18. Meril Life Sciences Pvt. Ltd.
17.19. MicroPort Scientific Corporation
17.20. OrbusNeich Medical Company Limited
17.21. Relisys Medical Devices Ltd.
17.22. Sahajanand Medical Technologies Limited
17.23. Sino Medical Sciences Technology Inc.
17.24. STENTYS SA
17.25. Terumo Corporation
17.26. Translumina GmbH
List of Figures
FIGURE 1. GLOBAL DRUG ELUTING STENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL DRUG ELUTING STENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL DRUG ELUTING STENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL DRUG ELUTING STENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2025 VS 2032 (%)
FIGURE 9. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL DRUG ELUTING STENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL POLYMER COATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL POLYMER COATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL POLYMER COATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIODEGRADABLE POLYMER COATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIODEGRADABLE POLYMER COATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIODEGRADABLE POLYMER COATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DURABLE POLYMER COATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DURABLE POLYMER COATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DURABLE POLYMER COATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL POLYMER FREE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL POLYMER FREE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL POLYMER FREE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIOLIMUS ELUTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIOLIMUS ELUTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOLIMUS ELUTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL EVEROLIMUS ELUTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL EVEROLIMUS ELUTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL EVEROLIMUS ELUTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PACLITAXEL ELUTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PACLITAXEL ELUTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PACLITAXEL ELUTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SIROLIMUS ELUTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SIROLIMUS ELUTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SIROLIMUS ELUTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL METALLIC STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL METALLIC STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL METALLIC STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL STAINLESS STEEL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL STAINLESS STEEL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL STAINLESS STEEL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COBALT CHROMIUM STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COBALT CHROMIUM STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COBALT CHROMIUM STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIORESORBABLE STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIORESORBABLE STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIORESORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL POLYMER BASED BIORESORBABLE STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL POLYMER BASED BIORESORBABLE STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL POLYMER BASED BIORESORBABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MAGNESIUM BASED STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MAGNESIUM BASED STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MAGNESIUM BASED STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CORONARY ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 100. EUROPE DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 103. EUROPE DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 104. EUROPE DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 105. EUROPE DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 106. EUROPE DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 107. EUROPE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 109. EUROPE DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 112. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. AFRICA DRUG ELUTING STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. AFRICA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 122. AFRICA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 123. AFRICA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 124. AFRICA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 125. AFRICA DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 126. AFRICA DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 127. AFRICA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. AFRICA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. AFRICA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. ASEAN DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. ASEAN DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 133. ASEAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 134. ASEAN DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 135. ASEAN DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 136. ASEAN DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 137. ASEAN DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 138. ASEAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. ASEAN DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. ASEAN DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 141. GCC DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GCC DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 143. GCC DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 144. GCC DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 145. GCC DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 146. GCC DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 147. GCC DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 148. GCC DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. GCC DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. GCC DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. BRICS DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. BRICS DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 163. BRICS DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 164. BRICS DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 165. BRICS DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 166. BRICS DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 167. BRICS DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 168. BRICS DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. BRICS DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. BRICS DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. G7 DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. G7 DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 173. G7 DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 174. G7 DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 175. G7 DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 176. G7 DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 177. G7 DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 178. G7 DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. G7 DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. G7 DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. NATO DRUG ELUTING STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. NATO DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 183. NATO DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 184. NATO DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 185. NATO DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 186. NATO DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 187. NATO DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 188. NATO DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. NATO DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. NATO DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL DRUG ELUTING STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 195. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 196. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 197. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 198. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. UNITED STATES DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 202. CANADA DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 203. CANADA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 204. CANADA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 205. CANADA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 206. CANADA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 207. CANADA DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 208. CANADA DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 209. CANADA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. CANADA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. CANADA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 212. MEXICO DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 213. MEXICO DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 214. MEXICO DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 215. MEXICO DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 216. MEXICO DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 217. MEXICO DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 218. MEXICO DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 219. MEXICO DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. MEXICO DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. MEXICO DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. BRAZIL DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 223. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 224. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 225. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 226. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 227. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 228. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 229. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. BRAZIL DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 234. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 235. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 236. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 238. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 239. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. UNITED KINGDOM DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. GERMANY DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. GERMANY DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 244. GERMANY DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 245. GERMANY DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 246. GERMANY DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 247. GERMANY DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 248. GERMANY DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 249. GERMANY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 250. GERMANY DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. GERMANY DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. FRANCE DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 253. FRANCE DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 254. FRANCE DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 255. FRANCE DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 256. FRANCE DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 257. FRANCE DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 258. FRANCE DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 259. FRANCE DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. FRANCE DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. FRANCE DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 262. RUSSIA DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 263. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 264. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 265. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 266. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 267. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 268. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 269. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 270. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. RUSSIA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 272. ITALY DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 273. ITALY DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 274. ITALY DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 275. ITALY DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 276. ITALY DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 277. ITALY DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 278. ITALY DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 279. ITALY DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 280. ITALY DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. ITALY DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 282. SPAIN DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 283. SPAIN DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 284. SPAIN DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 285. SPAIN DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 286. SPAIN DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 287. SPAIN DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 288. SPAIN DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 289. SPAIN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 290. SPAIN DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 291. SPAIN DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 292. CHINA DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 293. CHINA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 294. CHINA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 295. CHINA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 296. CHINA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 297. CHINA DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 298. CHINA DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 299. CHINA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 300. CHINA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 301. CHINA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 302. INDIA DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 303. INDIA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 304. INDIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 305. INDIA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 306. INDIA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 307. INDIA DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 308. INDIA DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 309. INDIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 310. INDIA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 311. INDIA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 312. JAPAN DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 313. JAPAN DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 314. JAPAN DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 315. JAPAN DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 316. JAPAN DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 317. JAPAN DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 318. JAPAN DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 319. JAPAN DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 320. JAPAN DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 321. JAPAN DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 322. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 323. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 324. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 325. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 326. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 327. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 328. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 329. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 330. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 331. AUSTRALIA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 332. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 333. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 334. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY POLYMER COATED, 2018-2032 (USD MILLION)
TABLE 335. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY DRUG, 2018-2032 (USD MILLION)
TABLE 336. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
TABLE 337. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
TABLE 338. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2032 (USD MILLION)
TABLE 339. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 340. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 341. SOUTH KOREA DRUG ELUTING STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 342. GLOBAL DRUG ELUTING STENT MARKET SHARE, BY KEY PLAYER, 2025
TABLE 343. GLOBAL DRUG ELUTING STENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Acrostak AG
  • Amaranth Medical Inc.
  • B. Braun SE
  • Balton Sp. z o.o.
  • Biosensors International Group Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Concept Medical Inc.
  • Elixir Medical Corporation
  • Endocor GmbH
  • iVascular S.L.U.
  • JW Medical Systems
  • Lepu Medical Technology Beijing Co. Ltd.
  • Medinol Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Company Limited
  • Relisys Medical Devices Ltd.
  • Sahajanand Medical Technologies Limited
  • Sino Medical Sciences Technology Inc.
  • STENTYS SA
  • Terumo Corporation
  • Translumina GmbH

Table Information

Report AttributeDetails
No. of Pages181
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.75 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.22 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032 - Product Image

Implantable Coronary Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Implantable Drug Eluting Stent Market - Global Forecast 2026-2032 - Product Image

Implantable Drug Eluting Stent Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Drug-Eluting Stents - Global Strategic Business Report - Product Image

Drug-Eluting Stents - Global Strategic Business Report

  • Report
  • 465 Pages
  • Global
From
Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region ?2026-2034? - Product Image

Drug-Eluting Stents Market Report by Coating, Drug, Stent Platform, Generation, Application, End User, and Region ?2026-2034?

  • Report
  • 149 Pages
  • Global
From
Drug Eluting Stent Market Report 2026 - Product Image

Drug Eluting Stent Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Drug Eluting Stent Market

The Drug Eluting Stent (DES) market is a subset of the drug delivery market. DES are medical devices used to treat coronary artery disease. They are inserted into the artery and release a drug over time to prevent the artery from narrowing again. The DES market has grown in recent years due to the increasing prevalence of cardiovascular diseases and the need for more effective treatments. The DES market is expected to continue to grow as new technologies are developed and the demand for more effective treatments increases. Some of the major players in the DES market include Abbott, Boston Scientific, Medtronic, Biotronik, and Terumo. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.